Compare CVV & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVV | HBIO |
|---|---|---|
| Founded | 1982 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 26.5M |
| IPO Year | 2007 | 2000 |
| Metric | CVV | HBIO |
|---|---|---|
| Price | $3.83 | $8.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 48.0K | 14.8K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.86 | N/A |
| EPS | ★ 1.58 | N/A |
| Revenue | $41,128,639.00 | ★ $116,176,000.00 |
| Revenue This Year | N/A | $3.76 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | $2.55 | ★ N/A |
| Revenue Growth | ★ 96.27 | N/A |
| 52 Week Low | $2.96 | $0.40 |
| 52 Week High | $9.10 | $9.00 |
| Indicator | CVV | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 68.10 |
| Support Level | $3.74 | $7.90 |
| Resistance Level | $4.44 | N/A |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 36.90 | 87.28 |
CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.